SoluBest, Ltd, today announced an agreement to license its proprietary nanotechnology platform for significantly improving the bio-performance of poorly soluble and insoluble drugs to CoreRx, Inc., an innovative contract formulation company. SoluBest’s Solumer™ technology is extremely versatile, as it can be applied to a wide range of pharmaceuticals. The license agreement will provide CoreRx with access to Solumer™ technology and the rights to apply the technology to client’s drug candidates currently in clinical development.
CoreRx, Inc. has announced its purchase of the former Formulated Solutions facility located at 14205 Myerlake Circle, just off Ulmerton Road in Clearwater. The new pharmaceutical facility located in the iCot Business Park, will more than triple the company's previous capacity and will accommodate projected growth through 2015.
CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include 15-cubic foot and 30-cubic foot V-shell blenders, a 43-station high speed tablet press, high speed encapsulation and a 40-inch solvent-capable coating pan. The additional equipment train will allow for increased clinical batch sizes in support of growing client demand. The additional equipment will allow CoreRx scientists to manufacture batch sizes of up to one million solid dosage units per day.